← Eichor
Study identifier: NCT07423936 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Multimodal Neuromonitoring During Normothermic Regional Perfusion for Organ Donors Determined Dead by circuLatory Criteria Following Withdrawal of Life Sustaining Measures

Condition: Organ Preservation · Brain Reperfusion or Regain of Brain Function During Normothermic Regional Perfusion  ·  Sponsor: University of British Columbia

PhaseN/A
Planned participants30
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this study is to demonstrate that cerebral blood flow and brain function do not resume after death declaration in organ donors who undergo normothermic regional perfusion to restore organ function following death determination by circulatory criteria, when appropriate safeguards are applied. To assess the absence of cerebral perfusion and function, investigators will use continuous and comprehensive multimodal neuromonitoring throughout the withdrawal of life-sustaining therapies, the dying process and the NRP procedure.

This description comes directly from the study's public registry record.

Talk to the study team

Rebecca Grey Clinical Research Coordinator  ·  604-875-4111  ·  cerebri.research@ubc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Vancouver General HospitalVancouver, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07423936